An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program

RecruitingOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Diffuse Large B Cell Lymphoma (DLBCL)
Trial Locations (11)

20132

RECRUITING

Irccs Ospedale San Raffaele, Milan

28100

RECRUITING

Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara

29100

RECRUITING

Ospedale Guglielmo da Saliceto di Piacenza, Piacenza

40138

RECRUITING

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

50134

RECRUITING

Azienda Ospedaliero Universitaria Careggi, Florence

90146

RECRUITING

Azienda Ospedaliera Villa Sofia Cervello, Palermo

Unknown

RECRUITING

AO Sant'Anna e San Sebastiano di Caserta, Caserta

RECRUITING

A.R.N.A.S. Garibaldi, Catania

RECRUITING

Azienda Ospedaliera Universitaria Arcispedale S. Anna, Ferrara

00144

RECRUITING

IRCCS- Istituto Nazionale Tumori Regina Elena, Roma

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER